Oncology Experts Highlight Top Takeaways From the 2025 AACR Annual Meeting

Experts from across oncology specialties shared some of the most talked-about abstracts and discussions from the 2025 AACR Annual Meeting. Ronny Drapkin, MD, PhD the Franklin Payne Professor of Pathology in Obstetrics & Gynecology, noted research to better understand features of aggressive disease in early precancers. Robert H. Vonderheide, MD, DPhil, director of the Abramson Cancer Center, agreed and emphasized that this type of basic science research is largely supported by federal funding. "Without that, we wouldn’t understand cancer biology as well as we might," he said.